null

Begelomab Biosimilar (Anti-CD26) Antibody (HDBS0134)

(No reviews yet) Write a Review
SKU:
HDBS0134
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Protein:
CD26
Reactivity:
Mouse
Host Species:
Mouse
Isotype:
IgG2b
€399

Description

system_update_altDatasheet

Begelomab (Anti-CD26) Biosimilar Antibody (HDBS0134)

The Begelomab Biosimilar Anti-CD26 Antibody is a cutting-edge product that targets the CD26 protein, a key molecule involved in immune regulation and cell signaling. This antibody, similar in structure and function to the original Begelomab antibody, is highly specific and reactive with human CD26 samples. It has been extensively validated for use in various experimental applications, including Western blotting and immunohistochemistry.CD26, also known as dipeptidyl peptidase-4 (DPP-4), is a multifunctional protein that plays a crucial role in immune response regulation and T cell activation.

By targeting CD26, researchers can gain valuable insights into immune function, cell signaling pathways, and potential therapeutic strategies for diseases such as cancer, autoimmune disorders, and inflammatory conditions.The Begelomab Biosimilar Anti-CD26 Antibody is a powerful tool for investigating the role of CD26 in immune modulation and disease pathogenesis. Its high specificity and sensitivity make it an invaluable asset for studies in immunology, oncology, and beyond. Unlock new possibilities in your research with the Begelomab Biosimilar Anti-CD26 Antibody.

0 Reviews

View AllClose